[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4404]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated October 21, 2009, and published in the Federal 
Register on October 28, 2009, (74 FR 55588), Johnson Matthey Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066-1742, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010).............................          I
Tetrahydrocannabinols (7370).................................          I
Dihydromorphine (9145).......................................          I
Difenoxin (9168).............................................          I
Propiram (9649)..............................................          I
Amphetamine (1100)...........................................         II
Methamphetamine (1105).......................................         II
Lisdexamfetamine (1205)......................................         II
Methylphenidate (1724).......................................         II
Nabilone (7379)..............................................         II
Cocaine (9041)...............................................         II
Codeine (9050)...............................................         II
Dihydrocodeine (9120)........................................         II
Oxycodone (9143).............................................         II
Hydromorphone (9150).........................................         II
Ecgonine (9180)..............................................         II
Hydrocodone (9193)...........................................         II
Meperidine (9230)............................................         II
Methadone (9250).............................................         II
Methadone intermediate (9254)................................         II
Morphine (9300)..............................................         II
Thebaine (9333)..............................................         II
Oxymorphone (9652)...........................................         II
Noroxymorphone (9668)........................................         II
Alfentanil (9737)............................................         II
Remifentanil (9739)..........................................         II
Sufentanil (9740)............................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4404 Filed 3-2-10; 8:45 am]
BILLING CODE 4410-09-P